Description

Telfast is an antihistamine drug that is a histamine H-1 receptor antagonist. It does not have a sedative or other effect on the central nervous system. The antiallergic effect appears after 1 hour, maximum after 6 hours, continues to act for 24 hours.

Indications: Relief of symptoms associated with seasonal allergic rhinitis (SAR) in adults and children over 12 years of age.

Mode of application: Allergic rhinitis: 60mg (1/2 tablet) 2 times a day before meals. SAD symptoms: 120mg once a day. Patients at risk. Studies in special risk groups (elderly patients, with renal and hepatic insufficiency) have shown that for patients in these categories no adjustment of the dosing regimen is required.

Contraindications: hypersensitivity to fexofenadine, terfenadine or other components of the drug. Side effects: Fexofenadine is generally well tolerated. The most frequently reported (1-10% of cases) headache, fatigue, dizziness or drowsiness, nausea. In placebo-controlled studies with a frequency of less than 1%, weakness, insomnia, nervousness, sleep disturbance, tachycardia, palpitations, diarrhea were noted. In rare cases (less than 0.1%), exanthema, urticaria, itching, Quincke’s edema, shortness of breath, shortness of breath, redness of the skin, anaphylactic reactions were observed. Pregnancy Category B: There are no adequate and well-controlled studies in pregnant women. Fexofenadine should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Lactation: Data on the content of fexofenadine in breast milk when taken by breastfeeding women are not available. Its penetration into breast milk was observed. The use of fexofenadine during lactation is not recommended.

Precautionary measures: Studies of elderly people, patients with liver failure and patients with heart disease exposed to fexofenadine did not reveal statistically significant differences compared with healthy people. As with most new drugs, data are limited in the elderly and in patients with renal or hepatic insufficiency. Fexofenadine hydrochloride should be used with caution in these special groups. Do not exceed the recommended dose of the drug. You should not drink fruit juices at the same time as fexofenadine: grapefruit, orange and apple can reduce its effectiveness. Drug interaction: co-administration with ketoconazole and erythromycin may cause an increase in the plasma concentration of fexofenadine. Antacids containing aluminum and magnesium can reduce the absorption of fexofenadine, the recommended interval between doses of these substances should be at least 2 hours. Influence on the ability to drive a car and performance of work requiring concentration of attention: it is possible to perform work that requires a high concentration of attention and speed of psychomotor reactions (with the exception of patients with a non-standard reaction). Therefore, it is recommended to check the individual response to fexofenadine before engaging in such activities.

Storage: Store at room temperature out of the reach of children.